Peter John Ratcliffe
Independent Non-Executive DirectorProfessor Sir Peter John Ratcliffe has been an Independent Non-Executive Director at Immunocore Holdings plc (formerly known as Immunocore Holdings Limited) since November 1, 2020. He is a Member of Advisory Panel at H2O Venture Partners (Manager) LLP. He co-founded ReOx in 2005, exploiting his groundbreaking research. He is a trained nephrologist and following an initial interest in renal erythropoietin regulation, he has also worked on the molecular and cellular physiology of oxygen sensitive signal pathways, publishing over 150 peer-reviewed manuscripts in this and other related fields. He has experience as a physician scientist. He currently serves as Director of Clinical Research at The Francis Crick Institute in London and Director for the Target Discovery Institute. He is the Head of the Clinical Division & Distinguished Scholar of the Ludwig Institute for Cancer Research of the Nuffield Department of Medicine at the University of Oxford. Previously, Professor he served as Nuffield Professor and Head of the Nuffield Department of Clinical Medicine from 2004 to 2016. He was elected to the Fellowship of the Royal Society and to the Academy of Medical Sciences in 2002. He was awarded the Nobel Prize for Physiology or Medicine in 2019. He got trained in medicine at Gonville and Caius College, Cambridge and St. Bartholomew's Hospital, London, before moving to Oxford to specialise in renal medicine. In 1990, with funding as a Wellcome Trust Senior Fellow, he set up the Hypoxia Biology laboratory in the Weatherall Institute of Molecular Medicine, Oxford. He is a member of European Molecular Biology Organization (EMBO), a foreign honorary member of the American Academy of Arts and Sciences and this year became a Fellow of the American Association for Cancer Research (AACR) Academy. His work has won a number of awards including the Louis-Jeantet Prize in Medicine, the Canada Gairdner International Award and the Lasker Award for Basic Biomedical Research. He was knighted for services to medicine in the New Year's Honours in 2014. He has earned a F.R.S. degree.
Positions
- Company NameImmunocore Holdings plcStock CodeIMCRPositionIndependent Non-Executive DirectorColleagues
- BJBahija JallalCEO & Executive Director
- JIJohn Irving BellIndependent Non-Executive Chairman
- TATravis Alan CoyCFO, Executive VP & Head of Corporate Development
- KRKripa RamExecutive VP & Chief Operating Officer
- JGJohn GollSVP, Finance & Chief Accounting Officer
- AVAnnelise VuidepotChief Science and Technology Officer & Milton Park Site Head
- KPKristine PetersonIndependent Non-Executive Director
- SKSiddharth KaulIndependent Non-Executive Director
